Your session is about to expire
← Back to Search
Photoacoustic Imaging for Soft Tissue Sarcoma
N/A
Waitlist Available
Led By Anurag Singh
Research Sponsored by Roswell Park Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights
Study Summary
This trial is testing how well a new low-risk imaging method, photoacoustic imaging, works in diagnosing changes in tumors in participants with breast cancer, sarcoma, skin cancer, or soft tissue malignancy and healthy volunteers.
Eligible Conditions
- Soft Tissue Sarcoma
- Healthy Subjects
- Sarcoma
- Skin Cancer
- Breast Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Feasibility of photoacoustic imaging (PAI) to quantify tumor characteristics
Secondary outcome measures
Hyperbaric oxygenation therapy
Utility of serial PAI measurements
Trial Design
1Treatment groups
Experimental Treatment
Group I: Diagnostic (photoacoustic imaging)Experimental Treatment1 Intervention
Participants undergo PAI on different parts of the body over 20 minutes for up to 5 imaging sessions for 6 months.
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,717 Previous Clinical Trials
40,953,357 Total Patients Enrolled
Roswell Park Cancer InstituteLead Sponsor
404 Previous Clinical Trials
31,294 Total Patients Enrolled
Anurag SinghPrincipal InvestigatorRoswell Park Cancer Institute
9 Previous Clinical Trials
209 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger